7 results
·
18ms
·
Sources: EU EUDAMED, US FDA
Fast PCR Mini Respiratory Panel
FDA 510(k)
FDA Class 2
·Microbiology
BlastGen
FDA 510(k)
FDA Class 2
·Obstetrics/Gynecology
CRYPTOSPORIDIUM II
FDA 510(k)
FDA Class 2
·Microbiology
PERSONA PEGGED POROUS TIBIAL COMPONENT
FDA Adverse Event
Injury
·ZIMMER, INC.·Product code OIY·November 12, 2014
PARADIGM REAL-TIME INSULIN INFUSION PUMP
FDA Adverse Event
Injury
·MEDTRONIC PUERTO RICO OPERATIONS MED-REL·Product code MDS·September 12, 2011
SYNCHROMED II
FDA Adverse Event
Injury
·MDT PUERTO RICO OPERATIONS CO·Product code LKK·July 29, 2013
Boston Scientific TELIGEN, Implantable Cardiac Defibrillator models E102, E110, the following models are not available in the US: models E103, E111, F102, F103, F110, F111. Sterilized using ethylene oxide. Product Usage: This family of implantable cardioverter defibrillators (ICDs) provide a variety of therapies including: -Ventricular tachyarrhythmia therapy, which is used to treat rhythms associated with sudden cardiac death such as VT and VF; -Bradycardia pacing, including adaptive rate pacing, to detect and treat bradyarrhythmias and to provide cardiac rate support after defibrillation therapy. Boston Scientific implantable cardioverter defibrillators (ICDs) are indicated to provide ventricular antitachycardia pacing (ATP) and ventricular defibrillation for automated treatment of life-threatening ventricular arrhythmias
FDA Enforcement
Class II
·Terminated·Boston Scientific CRM Corp·October 29, 2014